tm logo
TANNQUILYNNE
Live/Registered
REGISTERED

on 30 Mar 2021

Last Applicant/ Owned by

Xintai 5th Rd., Xizhi Dist

New Taipei City

TW

221

Serial Number

87914117 filed on 09th May 2018

Registration Number

6303591 registered on 30th Mar 2021

in the Principal Register

Correspondent Address

Michael T. Smith

Michael T. Smith

8110 Gatehouse Road, Suite 100 East

Falls Church, VA, 22042

Filing Basis

1. intent to use

Disclaimer

NO DATA

TANNQUILYNNE

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Phenol for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Syrups for pharmaceutical purposes for the treatment of de Read More

Classification Information


Class [005]
Pharmaceutical Products


Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Phenol for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Syrups for pharmaceutical purposes for the treatment of dementia; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating sunburn; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Medicinal herbal extracts for medical purposes; Antibacterial substances for medical purposes; Transdermal patches featuring medication for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plant; Herbal extracts for medical purposes; Phytotherapy preparations for medical purposes; Appetite suppressants for medical purposes; Beverages containing tannic acid for use as a nutritional supplement; Liquid nutritional supplement; Dietary and nutritional supplements; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of tannic acid; Dietary and nutritional supplements used for weight loss; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritional supplement for eliminating toxins from the body; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Powdered nutritional supplement drink mix containing tannic acid; Nutritional supplements for cats, dogs; Nutraceuticals for use as a dietary supplement for cognitive impairment; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement

Mark Details


Serial Number

No 87914117

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 6174-0130US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Mar 2021REGISTERED-PRINCIPAL REGISTER
12th Jan 2021PUBLISHED FOR OPPOSITION
12th Jan 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23rd Dec 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Dec 2020NOTICE OF ALLOWANCE CANCELLED
09th Dec 2020CASE RETURNED TO EXAMINATION
02th Dec 2020ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
02th Dec 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
01st Dec 2020ASSIGNED TO PETITION STAFF
02th Nov 2020ASSIGNED TO EXAMINER